Valuation: InterCure Ltd.

Market Cap 163M 0 146M 135M 122M 229M 15.46B 231M 1.62B 642M 8.1B 611M 598M 25.7B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 299M 0 268M 248M 225M 420M 28.41B 425M 2.97B 1.18B 14.89B 1.12B 1.1B 47.22B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
61.79%
Yield 2024 *
-
Yield 2025 -
1 day-2.55%
1 week-4.32%
Current month-18.07%
1 month-18.12%
3 months-5.63%
6 months+0.37%
Current year-15.08%
1 week 1,340
Extreme 1340
1,454
1 month 1,340
Extreme 1340
1,700
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,423.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 67 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%-4.32%-43.25%-37.83% 52.78M
-1.51%-3.82%+10.53%+37.47% 118B
-3.29%-3.39%-3.83%+99.72% 101B
+1.46%+1.21%+113.72%+973.76% 58.36B
+0.77%+3.23%-5.94%+90.00% 29.26B
+0.38%+2.49%+20.14%+66.45% 26.75B
-0.16%+2.29%+34.56%+89.97% 26.73B
-2.57%-3.77%+21.22%+393.32% 21.66B
-1.34%+1.24%-17.60%-1.87% 20.89B
-0.86%-21.25%-18.40%+56.75% 14.01B
Average -0.97%-2.26%+11.12%+176.78% 41.68B
Weighted average by Cap. -1.18%-1.93%+20.68%+209.70%

Financials

2024 2025
Net sales 239M 0 214M 198M 179M 335M 22.69B 340M 2.37B 942M 11.89B 897M 877M 37.71B 270M 0 243M 224M 203M 380M 25.67B 384M 2.68B 1.07B 13.45B 1.01B 993M 42.66B
Net income -67.8M -0 -60.85M -56.18M -50.95M -95.22M -6.44B -96.39M -674M -268M -3.38B -254M -249M -10.7B -35.71M -0 -32.05M -29.59M -26.84M -50.16M -3.39B -50.77M -355M -141M -1.78B -134M -131M -5.64B
Net Debt 133M 0 119M 110M 99.76M 186M 12.61B 189M 1.32B 524M 6.61B 498M 488M 20.96B 136M 0 122M 113M 102M 191M 12.95B 194M 1.35B 538M 6.79B 512M 501M 21.53B
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-10-26 ILA 1,374.00 -2.55% 10,410
26-10-23 ILA 1,410.00 -0.77% 241
26-10-22 ILA 1,421.00 -1.86% 5,573
26-10-21 ILA 1,448.00 +0.84% 4,068
26-10-20 ILA 1,436.00 +0.56% 10,037
  1. Stock Market
  2. Stocks
  3. INCR Stock